| 000 | 01432 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514043341.0 | ||
| 264 | 0 | _c20021108 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0920-9964 | ||
| 024 | 7 |
_a10.1016/s0920-9964(01)00311-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarenco, Stefano | |
| 245 | 0 | 0 |
_aPreliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series. _h[electronic resource] |
| 260 |
_bSchizophrenia research _cOct 2002 |
||
| 300 |
_a221-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDioxoles _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperidines _xadverse effects |
| 650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 700 | 1 | _aEgan, Michael F | |
| 700 | 1 | _aGoldberg, Terry E | |
| 700 | 1 | _aKnable, Michael B | |
| 700 | 1 | _aMcClure, Robert K | |
| 700 | 1 | _aWinterer, Georg | |
| 700 | 1 | _aWeinberger, Daniel R | |
| 773 | 0 |
_tSchizophrenia research _gvol. 57 _gno. 2-3 _gp. 221-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0920-9964(01)00311-5 _zAvailable from publisher's website |
| 999 |
_c12103577 _d12103577 |
||